January - February 2021 | Pulmonology

Advanced Search

Share

January - February 2021

Pulmonology

Pulmonology

ISSN: 2531-0437

Pulmonology (previously Revista Portuguesa de Pneumologia) is the official journal of the Portuguese Society of Pulmonology (Sociedade Portuguesa de Pneumologia/SPP). The journal publishes 6 issues per year, mainly about respiratory system diseases in adults and clinical research. This work can range from peer-reviewed original articles to review articles, editorials, and opinion articles. The journal is printed in English, and is freely available in its web page as well as in Medline and other databases.

Pulmonology has ceased to be published by Elsevier and is now published by Taylor & Francis available here.

See more

Pulmonology has ceased to be published by Elsevier and is now published by Taylor & Francis available here.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2023

10.4

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2023

14.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2023

1.284

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2023

1.534

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

portada-S2531043720X00079

Vol. 27. Issue 1.

Pages 1-90 (January - February 2021)

Download full issue
Download sponsored by SPP

Commentaries

Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the mask

Claudia Crimi, Annalisa Carlucci

Pulmonol. 2021;27:1-3

Open access

Open Article

Share

Tuberculosis — Reaping benefits from COVID-19 in Portugal

B.L. Mateiro Gomes, I. Carvalho

Pulmonol. 2021;27:4-6

Open access

Open Article

Share

Original articles

Original articles

Interstitial lung diseases

Translating Idiopathic pulmonary fibrosis guidelines into clinical practice

C. Robalo-Cordeiro, A. Morais

Pulmonol. 2021;27:7-13

Open access

Share

Low dose computed tomography of the lung for detection and grading of interstitial lung disease: A systematic simulation study

S. Ley, L. Fidler, H. Schenk, M. Durand, T. Marras, N. Paul, S. Shapera, S. Mittoo

Pulmonol. 2021;27:14-25

Open access

Share

Original articles

Lung cancer

The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer

A. Sakin, S. Sahin, M.M. atci, N. Yasar, C. Geredeli, F. Aksaray, S. Cihan

Pulmonol. 2021;27:26-34

Open access

Share

Original articles

Tuberculosis

Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency room

R. Singla, B. Raghu, A. Gupta, J.A. Caminero, P. Sethi, D. Tayal, A. Chakraborty, Y. Jain, G.B. Migliori

Pulmonol. 2021;27:35-42

Open access

Share

Reviews

The role of non-invasive ventilation in weaning and decannulating critically ill patients with tracheostomy: A narrative review of the literature

Miguel Guia, Laura D Ciobanu, Jithin K Sreedharan, Mohamed E. Abdelrahim, Gil Gonçalves, Bruno Cabrita, Jaber S. Alqahtani, Jun Duan, ... on behalf of International Association of Non Invasive Ventilation

Pulmonol. 2021;27:43-51

Open access

Share

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review

A. Cortegiani, M. Ippolito, M. Greco, V. Granone, A. Protti, C. Gregoretti, A. Giarratano, S. Einav, M. Cecconi

Pulmonol. 2021;27:52-66

Open access

Open Article

Share

Letters to the editor

COVID-19 effects on tuberculosis care in Sierra Leone

D. Buonsenso, F. Iodice, J. Sorba Biala, D. Goletti

Pulmonol. 2021;27:67-9

Open access

Open Article

Share

Extracorporeal membranous oxygenation for a severe case of vaping associated lung injury

M.R. Regmi, N. Tandan, P. Parajuli, R. Maini, O.E. Lara Garcia, P. Jagtap, A. Kulkarni

Pulmonol. 2021;27:69-70

Open access

Share

The “Big Five” Lung Diseases in CoViD-19 Pandemic – a Google Trends analysis

M.T. Barbosa, M. Morais-Almeida, C.S. Sousa, J. Bousquet

Pulmonol. 2021;27:71-2

Open access

Share

Total volume/week of physical activity: an underused variable of physical activity in daily life in patients with copd and its association with exercise capacity

Lorena P. Schneider, Felipe V.C. Machado, Antenor Rodrigues, Raquel P. Hirata, Daniele C. Dala Pola, Mariana P. Bertoche, Letícia F. Belo, Ana Carolina dos Reis Andrello, ... Fabio Pitta

Pulmonol. 2021;27:73-5

Open access

Share

Rhodococcus equi infection as inaugural manifestation of idiopathic CD4+ lymphopenia: A rare entity and a therapeutic challenge

A. Alves, E. Silva, T. Teixeira, C. Figueiredo, A. Lameirão, M. Vanzeller, C. Ribeiro

Pulmonol. 2021;27:75-7

Open access

Share

First case report in Latin America: Oral treatment of multidrug-resistant tuberculosis with delamanid and bedaquiline in combination with linezolid, moxifloxacin and clofazimine following a DRESS syndrome in a peruvian patient

S. Pecho-Silva, A.C. Navarro-Solsol

Pulmonol. 2021;27:77-9

Open access

Share

Alpha-1-antitrypsin deficiency (AATD) and spontaneous pneumothorax: Guidelines do not recommend screening for AATD in patients with pneumothorax – What did we find in 10 years of clinical evidence?

E. Dias, I. Farinha, F. Costa

Pulmonol. 2021;27:80-1

Open access

Share

Secondary pulmonary alveolar proteinosis in a patient with systemic lupus erythematosus

M. Yamasaki, K. Kawamoto, S. Nakano, M. Taniwaki, N. Matsumoto, N. Hattori

Pulmonol. 2021;27:81-3

Open access

Share

Correspondence

Potential survival paradox in pneumonia

H. Ito

Pulmonol. 2021;27:84

Open access

Share

Pneumonia mortality, comorbidities matter? Authors’ answer

V. Hespanhol, Cristina Bárbara

Pulmonol. 2021;27:85-6

Open access

Share

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?

C.S. Kow, S.S. Hasan

Pulmonol. 2021;27:86-7

Open access

Open Article

Share

Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply

A. Cortegiani, M. Ippolito, S. Einav

Pulmonol. 2021;27:87-8

Open access

Open Article

Share

Spontaneous pneumomediastinum: Beyond the risky diving

Jordi Juanola-Pla, Mireia Carmona-Tomàss, Sonia Casals-Vila

Pulmonol. 2021;27:88-9

Open access

Share

Wearing masks and the fight against the novel coronavirus (COVID-19)

Javad Alizargar

Pulmonol. 2021;27:89

Open access

Share

Pulmonology